POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 9 | / | 2022 | ||||||||
Date of issue: | 2022-02-07 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Sales revenues for January 2022 - Corrected | |||||||||||
Official market - legal basis | |||||||||||
art. 56. 1. 2 of Act on Public Offering. | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
“Sopharma” AD (the Company notifies that for January 2022 the Company recorded an increase in sales of 51% compared to the same month of the previous year, incl. normalization of domestic sales with an increase of 254% due to the low base and 35% decrease in export sales. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Sales_Revenues_for_January_2022_espi.pdf | Sales revenues for January 2022 - Corrected |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2022-02-07 | Ognian Donev | Executive Director |